Face-to-face with anti-inflammatory therapy for rosacea

1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases

(2013) Xiao Tan et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins

(2013) Xiao Tan et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease

(2013) J. M. Kahlenberg et al.   JOURNAL OF IMMUNOLOGY

Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel

(2013) Alvin B. Coda et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease

(2012) Markus Reinholz et al.   Annals of Dermatology

Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ

(2012) Stefania Briganti et al.   EXPERIMENTAL DERMATOLOGY

Quantification ofDemodex folliculorumby PCR in rosacea and its relationship to skin innate immune activation

(2012) Christiane Casas et al.   EXPERIMENTAL DERMATOLOGY

Antimicrobial peptides in the pathogenesis of psoriasis

(2012) Shin MORIZANE et al.   JOURNAL OF DERMATOLOGY

Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin

(2012) Kimberly N. Kanada et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Systemic Isotretinoin Therapy Normalizes Exaggerated TLR-2-Mediated Innate Immune Responses in Acne Patients

(2012) Melanie C. Dispenza et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The Coordinated Response of the Physical and Antimicrobial Peptide Barriers of the Skin

(2011) Andrew W. Borkowski et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Rosacea as a Disease of Cathelicidins and Skin Innate Immunity

(2011) Kenshi Yamasaki et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS

Wound healing activity of the human antimicrobial peptide LL37

(2011) Reinaldo Ramos et al.   PEPTIDES

Novel Sulfated Polysaccharides Disrupt Cathelicidins, Inhibit RAGE and Reduce Cutaneous Inflammation in a Mouse Model of Rosacea

(2011) Jianxing Zhang et al.   PLoS One

Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic Acid

(2010) Shin Morizane et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by Keratinocytes

(2010) Kenshi Yamasaki et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group

(2010) BE Elewski et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The molecular pathology of rosacea

(2009) Kenshi Yamasaki et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Current topical and systemic approaches to treatment of rosacea

(2009) HC Korting et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The roles of cathelicidin LL-37 in immune defences and novel clinical applications

(2008) Anastasia Nijnik et al.   CURRENT OPINION IN HEMATOLOGY

Antimicrobial peptides and the skin immune defense system

(2008) Jürgen Schauber et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY